Table 5.
Multivariate cox survival regression analyses of stent expansion for prognosis.
HR | p | Confidence interval | |
---|---|---|---|
Stent expansion (per 1%) | |||
MACE | 0.97 | 0.13 | 0.83–1.16 |
MACE (over-expansion excluded) | 0.95 | 0.03 | 0.82–0.98 |
No-reflow | 1.02 | 0.28 | 0.87–1.21 |
Optimal-expansion | |||
MACE | 0.75 | 0.08 | 0.50–1.12 |
No-reflow | 0.59 | 0.09 | 0.48–1.19 |
Under-expansion | |||
MACE | 0.82 | 0.43 | 0.55–1.20 |
No-reflow | 0.35 | 0.16 | 0.04–1.34 |
Over-expansion | |||
MACE | 1.45 | 0.007 | 1.22–1.56 |
No-reflow | 1.27 | 0.02 | 1.20–2.52 |
70%≤stent expansion <80% | |||
MACE | 1.11 | 0.08 | 0.93–1.51 |
No-reflow | 1.43 | 0.08 | 0.58–1.67 |
Stent expansion <70% | |||
MACE | 1.36 | 0.04 | 1.09–1.58 |
No-reflow | 1.74 | 0.06 | 0.73–2.28 |